Response

Response

Show other versions (2)

Bibliographic Details
Main Authors:	Bafadhel, M, Brightling, C, Siddiqui, S
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Response
by: Bafadhel, M, et al.
Published: (2011)

Response
by: Bafadhel, M, et al.
Published: (2011)

Inhaled glucocorticoids and COPD exacerbations.
by: Brightling, C, et al.
Published: (2015)

Characterising non-eosinophilic COPD
by: Hambleton, K, et al.
Published: (2015)

Free-living Haemophilus Influenzae is associated with increased pulmonary inflammation
by: Thulborn, S, et al.
Published: (2015)

The role of CT scanning in multidimensional phenotyping of COPD.
by: Bafadhel, M, et al.
Published: (2011)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.
by: Siva, R, et al.
Published: (2014)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
by: Bafadhel, M, et al.
Published: (2014)

Neutrophil elastase as a biomarker for bacterial infection in COPD
by: Thulborn, S, et al.
Published: (2019)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
by: Siva R, et al.
Published: (2014-02-01)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
by: Shrimanker, R, et al.
Published: (2017)

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.
by: Thulborn, S, et al.
Published: (2017)

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
by: Bafadhel, M, et al.
Published: (2011)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
by: Barker, B, et al.
Published: (2015)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
by: Eltboli, O, et al.
Published: (2014)

Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence.
by: Pashley, C, et al.
Published: (2012)

Airways Disease: Phenotyping Heterogeneity Using Measures of Airway Inflammation
by: Siddiqui Salman, et al.
Published: (2007-06-01)

Effect of corticosteroids on epithelial cell response to non-typeable haemophilus influenzae
by: Cane, J, et al.
Published: (2016)

Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD.
by: Doe, C, et al.
Published: (2010)

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD
by: Thulborn SJ, et al.
Published: (2017-04-01)

Late breaking abstract - Resistomics of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes
by: Ramsheh, M, et al.
Published: (2018)

S45 Evaluating the sensitivity and specificity of active neutrophil elastase as a biomarker for bacterial infection in subjects with copd
by: Thulborn, SJ, et al.
Published: (2016)

Prednisolone response in patients with COPD.
by: Pavord, I, et al.
Published: (2004)

Biomarkers predicting response to corticosteroid therapy in asthma.
by: Brightling, C, et al.
Published: (2005)

Modelling the effect of gravity on inert-gas washout outputs
by: Foy, B, et al.
Published: (2018)

Neutrophil elastase as a biomarker for bacterial infection in COPD
by: Samantha J. Thulborn, et al.
Published: (2019-07-01)

Detection of cell-dissociated non-typeable haemophilus influenzae in the airways of patients with chronic obstructive pulmonary disease
by: Thulborn, SJ, et al.
Published: (2020)

Detection of Cell-Dissociated Non-Typeable Haemophilus influenzae in the Airways of Patients with Chronic Obstructive Pulmonary Disease
by: Thulborn SJ, et al.
Published: (2020-06-01)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
by: Bafadhel M, et al.
Published: (2015-06-01)

Cell-dissociated haemophilus influenzae and bacteria-associated inflammatory mediators in the airways of patients with chronic obstructive pulmonary disease
by: Thulborn, SJ, et al.
Published: (2017)

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
by: Saha, S, et al.
Published: (2006)

Proning reduces ventilation heterogeneity in patients with elevated BMI: implications for COVID-19 pneumonia management?
by: Brody H. Foy, et al.
Published: (2020-07-01)

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
by: Brightling, C, et al.
Published: (2014)

Body mass and fat mass in refractory asthma: an observational 1 year follow-up study.
by: Bafadhel, M, et al.
Published: (2010)

Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.
by: Bafadhel, M, et al.
Published: (2009)

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
by: Bafadhel, M, et al.
Published: (2012)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
by: Shrimanker, R, et al.
Published: (2017)

Symptomatic COPD: is it time for triple therapy?
by: Bafadhel, M
Published: (2018)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
by: Brightling, C, et al.
Published: (2000)

Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease.
by: Barker, B, et al.
Published: (2014)